The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance

Krzysztof Batko, Jolanta Malyszko, Artur Jurczyszyn, David H. Vesole, Morie Gertz, Xavier Leleu, Anna Suska, Marcin Krzanowski, Władysław Sułowicz, Jacek S. Malyszko, Katarzyna Krzanowska

Research output: Contribution to journalArticlepeer-review

3 Scopus citations


Monoclonal gammopathy of renal significance (MGRS) has introduced a new perspective to several well-known disease entities impacting nephrology, haematology and pathology. Given the constantly changing disease spectrum of these entities, it is clinically imperative to establish diagnostic and treatment pathways supported by evidence-based medicine. MGRS is a disease of the kidney, secondary to plasma cell clonal proliferation or immune dysfunction, requiring therapeutic intervention to eradicate the offending clone. To fully understand the disease(s), it is prerequisite to determine the significance of the findings. The diagnostic work up should be extensive due to the wide heterogeneity of clinical presentation, ultimately necessitating kidney biopsy. Particular patient profiles such as AL amyloidosis, which may be diagnosed through biopsies of other tissues/organs, may be an exception. Treatment decisions should be formulated by multi-disciplinary consensus: nephrologists, haematologists and pathologists. The ultimate goal in managing MGRS is eradication of the offending plasma cell clone which requires targeted chemotherapy and, in eligible cases, haematopoietic stem cell transplantation. We present a review of diagnostic procedures, treatment options and advances in the last few years in the management of MGRS in an effort to acquaint specialists with this new face of several older diseases.

Original languageEnglish (US)
Pages (from-to)1440-1452
Number of pages13
JournalNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Issue number9
StatePublished - Sep 1 2019


  • amyloidosis
  • kidney function
  • monoclonal gammopathy of renal significance
  • monoclonal gammopathy of undetermined significance
  • multiple myeloma

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Fingerprint Dive into the research topics of 'The clinical implication of monoclonal gammopathies: monoclonal gammopathy of undetermined significance and of renal significance'. Together they form a unique fingerprint.

Cite this